10-128040972-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006504.6(PTPRE):c.91G>A(p.Glu31Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006504.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPRE | ENST00000254667.8 | c.91G>A | p.Glu31Lys | missense_variant | 3/21 | 1 | NM_006504.6 | ENSP00000254667.3 | ||
PTPRE | ENST00000455661.5 | c.91G>A | p.Glu31Lys | missense_variant | 2/6 | 2 | ENSP00000416939.1 | |||
PTPRE | ENST00000471218.5 | c.91G>A | p.Glu31Lys | missense_variant | 2/6 | 3 | ENSP00000474102.1 | |||
PTPRE | ENST00000442830.5 | c.91G>A | p.Glu31Lys | missense_variant | 4/7 | 5 | ENSP00000410540.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251052Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135758
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727224
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 19, 2024 | The c.91G>A (p.E31K) alteration is located in exon 3 (coding exon 1) of the PTPRE gene. This alteration results from a G to A substitution at nucleotide position 91, causing the glutamic acid (E) at amino acid position 31 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at